IL15 and hematologic disorder: Although there are encouraging pre-clinical and clinical results indicating that IL-15 can potentially be utilized as a powerful immunotherapeutic agent [92,93], it is important to note that evidence exists showing certain IL-15 isoforms or complexes might also play a pro-tumorigenic role in hematological malignancies [94] or solid tumors [41,95].